Psychiatric Symptom Predictors in Methamphetamine-Induced Psychosis
Recruiting
Observational Study
Methamphetamine Induced Psychosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 65
- Sex
- Male
- Study type
- Observational
- Participants needed
- 150 (estimated)
- Sponsor
- Elazığ Mental Health and Diseases Hospital · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This longitudinal observational study aimed to investigate environmental, familial, and individual factors associated with psychiatric symptom severity in participants diagnosed with methamphetamine-induced psychotic disorder (MP). Participants diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5-TR) criteria was followed/will be followed prospectively…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
* Methamphetamine-Induced Psychotic Disorder (MP) Group:
\*Inclusion Criteria:
* Diagnosis of MP according to DSM-5-TR
* Medication-free for at least one month prior to admission
* Age ≥ 18 years and \<65 years
* Provided informed consent
* Methamphetamine-Induced Psychotic Disorder (MP) …
Contacts